PATENT CLAIM ANALYSIS

Application Number: 15745903
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-08
Patent Classification: ["514", "734000"]

Abstract:
Peritoneal therapeutic fluid comprising one or more of a biocompatibility enhancing agent (BCA) that is selected from the group consisting of a polyphenolic compound, a metabolite of a polyphenolic compound which is obtained by metabolization in the human or animal body, a salt or a glycoside of a polyphenolic compound.

Claim (Index 1):
A peritoneal therapeutic fluid comprising one or more of a biocompatibility enhancing agent (BCA) that is selected from the group consisting of a polyphenolic compound, a metabolite of a polyphenolic compound which is obtained by metabolization in the human or animal body, a salt of a polyphenolic compound, a glycoside of a polyphenolic compound, a derivative of a polyphenolic compound, polyethylene glycol (PEG), or a derivative of a polyethylene glycol, for use as a peritoneal dialysis fluid, or as a peritoneal therapeutic fluid with decreased cytotoxicity on human peritoneal mesothelial cells.

Metadata:
- Claim Count in Document: 80.0
- Percentile: 86.0
- Lexical Diversity: 1.48649
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['15523591', '11997765', '14084793', '13984991', '11554056']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7198019595579689
- 35 USC 102 Novelty (BERT): 0.499734292562084
- Combined Prediction Score: 0.6977951928583804
- Mean Citation Score: 187.43985
- Max Citation Score: 194.85373
- Similarity Product: 120.08238154228452

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test